Modern prognostic factors and angiogenesis in chronic lymphocytic leukemia: more data needed

Leuk Res. 2007 Dec;31(12):1763-4. doi: 10.1016/j.leukres.2007.05.016. Epub 2007 Jul 6.

Abstract

Angiogenesis appears to be an important player in biology of chronic lymphocytic leukemia (CLL). We present here data on association of ZAP-70 expression measured by flow cytometry and plasma levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in 27 untreated CLL patients. We found significantly higher VEGF (but not bFGF) in ZAP-negative patients. Likewise, there was a negative correlation between percentage of ZAP-70 expression and VEGF. Larger, prospective studies are needed to confirm our pilot data.

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Fibroblast Growth Factor 2 / blood
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
  • Male
  • Middle Aged
  • Neovascularization, Pathologic / diagnosis*
  • Pilot Projects
  • Prognosis
  • Vascular Endothelial Growth Factor A / blood
  • ZAP-70 Protein-Tyrosine Kinase / analysis

Substances

  • Vascular Endothelial Growth Factor A
  • Fibroblast Growth Factor 2
  • ZAP-70 Protein-Tyrosine Kinase
  • ZAP70 protein, human